Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Заявленная компания
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions читать еще
teamwork, helping people, getting something done
Что самое позитивное вы можете сказать о культуре и обстановке на вашей работе?
that it seems to be changing for the better
Каковы самые лучшие качества в вашей команде?
the good people on our team are the most collaborative I've ever worked with
Почему вы чувствуете себя недооцененным(ой), и как ваша зарплата могла бы на это повлиять?
seeing others who do less than me get promoted over me doesn't make me want to work harder, especially when that someone dumps their work on me
Other Employee Reviews for Karyopharm Therapeutics
×